NCT06128304 ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services
| NCT ID | NCT06128304 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, San Diego |
| Condition | HIV |
| Study Type | INTERVENTIONAL |
| Enrollment | 2,436 participants |
| Start Date | 2023-11-13 |
| Primary Completion | 2026-12-01 |
Trial Parameters
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
While there has been a significant increase in the uptake of antiretroviral therapy among women living with HIV (WLHIV) in many low- and-middle income countries (LMICs), the coverage of cervical cancer screening and treatment (CCST) among WLHIV remains low. This study aims to leverage the available infrastructure for HIV care and treatment programs in Nigeria to integrate cervical cancer screening and treatment and conduct a cluster randomized, hybrid type III trial design to assess the comparative effectiveness of a Core set of implementation strategies versus a Core+ (enhanced) set of implementation strategies to implement cervical cancer screening, onsite treatment, referral and referral completion, treatment, and retention in care among WLHIV. The overarching goal is to improve the health and life expectancy of WLHIV with co-occurring cervical cancer.
Eligibility Criteria
Inclusion Criteria: * Women living with HIV Exclusion Criteria: \-
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.